India: True North sells stake in drug research firm Syngene for $66m

India: True North sells stake in drug research firm Syngene for $66m

visual from the company website

Private equity firm True North – earlier known as India Value Fund Advisors – has part-exited its investment in its over two-and-a-half years old firm portfolio firm Syngene International Ltd through a bulk market transaction.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter